DCR-PHXC

· Dicerna Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DCR-PHXC, covering 2024-05-22 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD [Phase 2]